Searcharxiv⌕ Search

arXiv · physics/0304019

GPCALMA, a mammographic CAD in a GRID connection

Abstract

Purpose of this work is the development of an automatic system which could be useful for radiologists in the investigation of breast cancer. A breast neoplasia is often marked by the presence of microcalcifications and massive lesions in the mammogram: hence the need for tools able to recognize such lesions at an early stage. GPCALMA (Grid Platform Computer Assisted Library for MAmmography), a collaboration among italian physicists and radiologists, has built a large distributed database of digitized mammographic images (at this moment about 5500 images corresponding to 1650 patients). This collaboration has developed a CAD (Computer Aided Detection) system which, installed in an integrated station, can also be used for digitization, as archive and to perform statistical analysis. With a GRID configuration it would be possible for the clinicians tele- and co-working in new and innovative groupings ('virtual organisations') and, using the whole database, by the GPCALMA tools several analysis can be performed. Furthermore the GPCALMA system allows to be abreast of the CAD technical progressing into several hospital locations always with remote working by GRID connection. We report in this work the results obtained by the GPCALMA CAD software implemented with a GRID connection.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

U. Bottigli, P. G. Cerello, P. Delogu, M. E. Fantacci, F. Fauci, B. Golosio, A. Lauria, E. Lopez Torres, R. Magro, G. L. Masala, P. Oliva, R. Palmiero, G. Raso, A. Retico, S. Stumbo, S. Tangaro. 2003-04-07. GPCALMA, a mammographic CAD in a GRID connection. https://arxiv.org/abs/physics/0304019

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

Light-sheet microscopy in cancer pathology: current applications, clinical challenges and future perspectives

Light-sheet fluorescence microscopy (LSFM) has emerged as a powerful research technology for three-dimensional (3D) visualization of biological tissues and is increasingly applied to human cancer specimens, including optically cleared biopsies and surgical resection samples. In this Perspective article, we review current applications of LSFM in oncology, and discuss how recent developments in microscopy, tissue preparation, labelling, and computational analysis are expanding the possibilities of 3D cancer pathology. Although LSFM has demonstrated the feasibility of large-volume imaging in selected human specimens, its application remains predominantly within research and translational settings and is not currently part of routine clinical pathology. We therefore distinguish demonstrated applications from potential future uses. We discuss how LSFM could eventually contribute to selected diagnostic and surgical workflows by providing 3D information on tumour architecture, spatial heterogeneity, metastatic dissemination, and surgical margins. These applications remain prospective and will require substantial technical, clinical, regulatory, computational, and workflow validation before clinical implementation can be considered. Ultimately, LSFM may complement rather than replace conventional histopathology by extending pathological assessment from two-dimensional tissue sections towards 3D spatial analysis.

physics.med-ph↗

Quantitative Ultrasound Perfusion Biomarker: Cross-Modality Validation with Laser Speckle Imaging

Rationale and Objectives: Tooth extraction can cause alveolar bone resorption and variable healing despite socket preservation. Current perfusion assessment relies largely on visual evaluation, limiting objective monitoring of socket healing. We developed and validated a quantitative color flow ultrasound framework to reduce sensitivity to imaging settings and motion artifacts. Materials and Methods: Color flow ultrasound data were acquired longitudinally in 30 patients undergoing tooth extraction and grafting. Velocity- and power-weighted color pixel density (CPDvel and CPDpwr) were derived from complex-valued color flow (TRI) data at 0-1.5 mm beneath the epithelial surface. Gain robustness was assessed using a Quantitative Imaging Biomarker Alliance (QIBA) flow phantom. Concurrent laser speckle contrast imaging (LASCA) provided in vivo comparison. Results: Phantom velocity estimates remained stable across color gain settings of 20-100 a.u. at flow rates of 2, 4, 6, and 8 mL/s. Perfusion metrics decreased over approximately 2-30 weeks after extraction. Nonlinear fits yielded R2 values of 0.74 for CPDvel, 0.45 for CPDpwr, and 0.66 for LASCA. Exponential half-decay times were 60.3, 92.4, and 48.3 days, respectively, relative to the first post-extraction measurement. LASCA correlated linearly with ultrasound-derived velocity (R2 = 0.68) and power (R2 = 0.74; both p < 0.05). Conclusions: The framework supports noninvasive, quantitative monitoring of superficial perfusion during socket healing with reduced sensitivity to color gain. Direct analysis of TRI data provides depth-specific perfusion metrics and may improve consistency across imaging sessions. Further validation is needed to determine its ability to identify compromised healing and inform clinical decisions.

physics.med-ph↗

LesionStudio: A Patient-Informed Platform for Task-Specific Optimization of Emission Tomography Reconstructions

Purpose: For task-specific PET and SPECT reconstruction optimization, we developed LesionStudio, an open-source platform incorporating patient background heterogeneity, realistic lesion morphology and texture, and lesion-background interactions beyond conventional phantoms. Methods: LesionStudio, a Python framework built on PyTomography, inserts lesions into PET/SPECT data using modality-specific forward projection and stochastic background ablation. Clinical realism was evaluated by physician review of 30 inserted lesions in eight DLBCL patients from a 1,579-lesion FDG lymphoma library. Quantification and detectability were assessed in FDG PET using spherical and patient-derived lesions varying in size, LBR, and site, reconstructed with OSEM and BSREM. Results: Inserted lesions were visually indistinguishable from true disease (AUC = 0.49). OSEM improved the patient-derived quantification limit from ~3.7 mL at iteration 4 to ~2.0 mL at iteration 10, but with increased noise and edge artifacts. Weakly regularized BSREM (beta = 5) achieved a similar ~2.0 mL limit with stability, whereas stronger regularization increased under-recovery. Detectability was contrast-dependent: no lesions were detected at LBR 2:1, whereas detectable volume ranged from 0.70 to 3.63 mL at LBR 4:1 and decreased to 0.70 mL at LBR 6:1-8:1 for both OSEM and weakly regularized BSREM. Conclusion: Reconstruction settings can shift SUV metrics and detectability enough to affect interpretation, so no single protocol suits every task. OSEM required early stopping for detection and feature stability but more iterations for mean-SUV quantification, whereas weakly regularized BSREM matched both at one setting. LesionStudio (https://github.com/qurit/LesionStudio), with our public library of realistic lesions, provides a reproducible framework for task-specific optimization across radiopharmaceuticals and scanners.

physics.med-ph↗